{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:38:49Z","timestamp":1793263129685,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine Plus"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.phyplu.2022.100252","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:07:14Z","timestamp":1646399234000},"page":"100252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking"],"prefix":"10.1016","volume":"2","author":[{"given":"Junfeng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-9752","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phyplu.2022.100252_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/721608","article-title":"The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis","volume":"2011","author":"Barnes","year":"2011","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2019.11.027","article-title":"AAV1.SERCA2a gene therapy reverses pulmonary fibrosis by blocking the STAT3\/FOXM1 pathway and promoting the SNON\/SKI axis","volume":"28","author":"Bisserier","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phyplu.2022.100252_bib0003","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1158\/0008-5472.CAN-05-2919","article-title":"Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis","volume":"66","author":"Blavier","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0004","article-title":"Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis","volume":"17","author":"Chen","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phyplu.2022.100252_bib0005","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1039\/D0CP00831A","article-title":"The application of the MM\/GBSA method in the binding pose prediction of FGFR inhibitors","volume":"22","author":"Chen","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.phyplu.2022.100252_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.toxlet.2013.03.009","article-title":"berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-\u03baB dependant TGF-\u03b2 activation: a biphasic experimental study","volume":"219","author":"Chitra","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phyplu.2022.100252_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00109-015-1283-1","article-title":"Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis","volume":"93","author":"Chitra","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0008","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1080\/07391102.2020.1803968","article-title":"In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach","volume":"39","author":"Chowdhury","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.phyplu.2022.100252_bib0009","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1021\/acs.jproteome.0c00387","article-title":"A Chain only as strong as its weakest link\": an up-to-date literature review on the bidirectional interaction of pulmonary fibrosis and COVID-19","volume":"19","author":"Crisan-Dabija","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-1536-4-23","article-title":"Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes","volume":"4","author":"Ekert","year":"2011","journal-title":"Fibrogenesis Tissue Repair."},{"key":"10.1016\/j.phyplu.2022.100252_bib0011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0014-4827(02)00015-0","article-title":"TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins","volume":"282","author":"Evans","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2018.02.001","article-title":"Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-\u03b3 and subsequent expression of HGF in colons","volume":"343","author":"Guan","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0014","doi-asserted-by":"crossref","DOI":"10.1063\/1.4872239","article-title":"Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity","volume":"140","author":"Harrach","year":"2014","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.phyplu.2022.100252_bib0015","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jcp.26112","article-title":"TNF-\u03b1-induced NF-\u03baB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis","volume":"233","author":"Hou","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.intimp.2016.08.008","article-title":"Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: Role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress","volume":"39","author":"Kabel","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12931-015-0261-z","article-title":"Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis","volume":"16","author":"Kobayashi","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0018","doi-asserted-by":"crossref","DOI":"10.1063\/1.2464095","article-title":"Langevin stabilization of molecular-dynamics simulations of polymers by means of quasisymplectic algorithms","volume":"126","author":"Larini","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.phyplu.2022.100252_bib0019","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00613","article-title":"Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery","volume":"60","author":"Lee","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.phyplu.2022.100252_bib0020","first-page":"2385","article-title":"Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats","volume":"18","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphar.2019.00009","article-title":"A natural isoquinoline alkaloid with antitumor activity: studies of the biological activities of berberine","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/rcmb.2005-0253OC","article-title":"The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6","volume":"37","author":"Liu","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0023","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.200410-1349OC","article-title":"Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype","volume":"171","author":"Lundblad","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0024","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1164\/rccm.200712-1827OC","article-title":"Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis","volume":"179","author":"Mercer","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12931-018-0728-9","article-title":"The JAK2 pathway is activated in idiopathic pulmonary fibrosis","volume":"19","author":"Milara","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0026","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury","volume":"166","author":"Moore","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1165\/rcmb.2005-0239OC","article-title":"The role of CCL12 in the recruitment of fibrocytes and lung fibrosis","volume":"35","author":"Moore","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0028","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","article-title":"Hyper-responsiveness of IPF\/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2","volume":"40","author":"Murray","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0029","doi-asserted-by":"crossref","first-page":"e9683","DOI":"10.1371\/journal.pone.0009683","article-title":"Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages","volume":"5","author":"Murray","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phyplu.2022.100252_bib0032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/emmm.201100604","article-title":"Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis","volume":"4","author":"O'Donoghue","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0033","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","article-title":"Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-\u03b2 (TGF-\u03b2) signaling promoting SMAD3 activation and fibrosis via Gremlin protein","volume":"289","author":"O'Reilly","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phyplu.2022.100252_bib0034","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-08-0511","article-title":"Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis","volume":"68","author":"Pandey","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1096\/fj.15-273953","article-title":"STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation","volume":"30","author":"Pedroza","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.phyplu.2022.100252_bib0036","first-page":"5217","article-title":"Antibacterial activity and mechanism of berberine against Streptococcus agalactiae","volume":"8","author":"Peng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0037","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/344245a0","article-title":"Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis","volume":"344","author":"Piguet","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.phyplu.2022.100252_bib0038","first-page":"651","article-title":"Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis","volume":"143","author":"Piguet","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0039","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phyplu.2022.100252_bib0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"Saito","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0041","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/cbdd.13160","article-title":"Cucurbitacin-B attenuates CCl4 -induced hepatic fibrosis in mice through inhibition of STAT-3","volume":"91","author":"Sallam","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.phyplu.2022.100252_bib0042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0043","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/labinvest.2013.108","article-title":"All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-\u03b21\/Smad3 signaling pathway in rats","volume":"93","author":"Song","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phyplu.2022.100252_bib0044","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jmv.25735","article-title":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis","volume":"92","author":"Sun","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/qjmed\/hcaa255","article-title":"Post-COVID-19 pneumonia pulmonary fibrosis","volume":"113","author":"Tale","year":"2020","journal-title":"QJM"},{"key":"10.1016\/j.phyplu.2022.100252_bib0046","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/kisup.2014.16","article-title":"Wnt\/\u03b2-catenin signaling and kidney fibrosis","volume":"4","author":"Tan","year":"2014","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.phyplu.2022.100252_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.108947","article-title":"Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases","volume":"317","author":"Tew","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phyplu.2022.100252_bib0048","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","article-title":"The many faces and functions of \u03b2-catenin","volume":"31","author":"Valenta","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.phyplu.2022.100252_bib0049","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbrc.2011.08.109","article-title":"TNF-\u03b1 increases cardiac fibroblast lysyl oxidase expression through TGF-\u03b2 and PI3Kinase signaling pathways","volume":"413","author":"Voloshenyuk","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phyplu.2022.100252_bib0050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phyplu.2022.100252_bib0051","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/molecules22081257","article-title":"Synthesis and identification of novel berberine derivatives as potent inhibitors against TNF-\u03b1-induced NF-\u03baB activation","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.phyplu.2022.100252_bib0052","doi-asserted-by":"crossref","first-page":"ftaa047","DOI":"10.1093\/femspd\/ftaa047","article-title":"Berberine functions as a negative regulator in lipopolysaccharide -induced sepsis by suppressing NF-\u03baB and IL-6 mediated STAT3 activation","volume":"78","author":"Wang","year":"2020","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.phyplu.2022.100252_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7173920","article-title":"Update on the benefits and mechanisms of action of the bioactive vegetal alkaloid berberine on lipid metabolism and homeostasis","volume":"2018","author":"Wang","year":"2018","journal-title":"Cholesterol"},{"key":"10.1016\/j.phyplu.2022.100252_bib0054","doi-asserted-by":"crossref","first-page":"e21360","DOI":"10.1096\/fj.202001792R","article-title":"A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: a computational and mechanistic study","volume":"35","author":"Wang","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.phyplu.2022.100252_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0056","first-page":"75","article-title":"Interpretation of the 7th edition of the \"diagnosis and treatment guidelines of coronavirus disease 2019 in China\": progress and challenges","volume":"6","author":"Xie","year":"2020","journal-title":"Chronic Dis. Transl. Med."},{"key":"10.1016\/j.phyplu.2022.100252_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5273914","article-title":"Molecular mechanism of the effect of Huanglian jiedu decoction on type 2 diabetes mellitus based on network pharmacology and molecular docking","volume":"2020","author":"Yin","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.phyplu.2022.100252_bib0058","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jmv.26634","article-title":"Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19","volume":"93","author":"Zhang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.phyplu.2022.100252_bib0059","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jprot.2016.07.014","article-title":"Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition","volume":"148","author":"Zhao","year":"2016","journal-title":"J. Proteomics"}],"container-title":["Phytomedicine Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667031322000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667031322000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:28:30Z","timestamp":1793262510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667031322000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2667031322000380"],"URL":"https:\/\/doi.org\/10.1016\/j.phyplu.2022.100252","relation":{},"ISSN":["2667-0313"],"issn-type":[{"value":"2667-0313","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phyplu.2022.100252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100252"}}